Piershale Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15	Closed	-$4.73K	–	300
2023 Q1	$4.73K	Hold	15	–	–	﹤0.01%	175
2022 Q4	$4.33K	Buy	+15	New	+$4.33K	﹤0.01%	193